Cabot (NYSE:CBT) Releases FY 2025 Earnings Guidance

Cabot (NYSE:CBTGet Free Report) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 7.400-7.800 for the period, compared to the consensus estimate of 7.060. The company issued revenue guidance of -. Cabot also updated its FY25 guidance to $7.40-7.80 EPS.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Mizuho lifted their price target on shares of Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a research report on Tuesday. JPMorgan Chase & Co. boosted their target price on Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. Finally, UBS Group cut their target price on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $105.00.

Check Out Our Latest Stock Report on CBT

Cabot Stock Up 6.9 %

Shares of NYSE:CBT traded up $7.51 during trading on Wednesday, hitting $116.37. The company’s stock had a trading volume of 331,254 shares, compared to its average volume of 337,930. The business has a 50 day moving average price of $108.41 and a two-hundred day moving average price of $101.13. The company has a market capitalization of $6.38 billion, a PE ratio of 12.95, a P/E/G ratio of 0.91 and a beta of 1.20. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. Cabot has a fifty-two week low of $68.11 and a fifty-two week high of $117.37.

Cabot (NYSE:CBTGet Free Report) last posted its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing the consensus estimate of $1.81 by ($0.01). The business had revenue of $1 billion during the quarter, compared to analyst estimates of $1.01 billion. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The business’s revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.65 EPS. As a group, research analysts expect that Cabot will post 7.07 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Hobart Kalkstein sold 5,457 shares of the business’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total transaction of $548,865.06. Following the completion of the transaction, the executive vice president now owns 61,688 shares in the company, valued at approximately $6,204,579.04. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Hobart Kalkstein sold 5,457 shares of the company’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total transaction of $548,865.06. Following the completion of the transaction, the executive vice president now owns 61,688 shares of the company’s stock, valued at $6,204,579.04. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 48,665 shares of company stock worth $4,986,299. Corporate insiders own 3.07% of the company’s stock.

About Cabot

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Articles

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.